INSULET CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
INSULET CORPORATION (PODD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $28.40 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-18.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-02-18
- INSULET CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2019-12-31 was $19.99M, a 860.79% increase year-over-year.
- INSULET CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2019-09-30 was $49.96M, a 1036.84% increase year-over-year.
- INSULET CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2019-06-30 was $33.43M, a 188.56% increase year-over-year.
- INSULET CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2019-03-31 was $15.81M, a 190.73% increase year-over-year.
- INSULET CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $28.40M, a 72.12% increase from fiscal 2024.
- INSULET CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $16.50M, a 68.69% decline from fiscal 2023.
- INSULET CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $52.70M, a 66.25% increase from fiscal 2022.
- INSULET CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $31.70M, a 63.35% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $28.40M 10-K · filed 2026-02-18 | |||||||
| 2024-12-31 | $16.50M 10-K · filed 2026-02-18 | |||||||
| 2023-12-31 | $52.70M 10-K · filed 2026-02-18 | |||||||
| 2022-12-31 | $31.70M 10-K · filed 2025-02-21 | |||||||
| 2021-12-31 | $86.50M 10-K · filed 2024-02-23 | |||||||
| 2020-12-31 | $115.90M 10-K · filed 2023-02-24 | |||||||
| 2019-12-31 | $19.99M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $69.96M derived: sum of 2 quarters · filed 2022-02-24 | $103.39M derived: sum of 3 quarters · filed 2022-02-24 | $119.20M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | $49.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $83.40M derived: sum of 2 quarters · filed 2019-11-06 | $99.21M 10-Q · filed 2019-11-06 | $101.29M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-06-30 | $33.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $49.24M 10-Q · filed 2019-08-06 | $51.32M derived: sum of 3 quarters · filed 2021-02-24 | $55.72M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-03-31 | $15.81M 10-Q · filed 2019-05-03 | $17.89M derived: sum of 2 quarters · filed 2021-02-24 | $22.29M derived: sum of 3 quarters · filed 2021-02-24 | $33.87M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2018-12-31 | $2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $6.48M derived: sum of 2 quarters · filed 2021-02-24 | $18.06M derived: sum of 3 quarters · filed 2021-02-24 | $23.50M 10-K · filed 2021-02-24 | $23.48M 10-K · filed 2019-02-26 | |||
| 2018-09-30 | $4.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $15.98M derived: sum of 2 quarters · filed 2018-11-02 | $21.42M 10-Q · filed 2018-11-02 | $25.52M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-06-30 | $11.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $17.02M 10-Q · filed 2018-08-02 | $21.13M derived: sum of 3 quarters · filed 2020-02-26 | $23.42M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-03-31 | $5.44M 10-Q · filed 2018-05-04 | $9.54M derived: sum of 2 quarters · filed 2020-02-26 | $11.84M derived: sum of 3 quarters · filed 2020-02-26 | $12.34M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2017-12-31 | $4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $6.40M derived: sum of 2 quarters · filed 2020-02-26 | $6.90M derived: sum of 3 quarters · filed 2020-02-26 | $11.80M 10-K · filed 2020-02-26 | $11.85M 10-K · filed 2018-02-22 | |||
| 2017-09-30 | $2.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $2.80M derived: sum of 2 quarters · filed 2018-08-02 | $7.70M 10-Q · filed 2017-11-03 | $7.90M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $5.40M 10-Q · filed 2018-08-02 | $5.41M 10-Q · filed 2017-08-04 | $5.60M derived: sum of 3 quarters · filed 2019-02-26 | $9.00M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-03-31 | $4.90M 10-Q · filed 2018-05-04 | $4.88M 10-Q · filed 2017-05-09 | $5.10M derived: sum of 2 quarters · filed 2019-02-26 | $8.50M derived: sum of 3 quarters · filed 2019-02-26 | $8.70M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $3.60M derived: sum of 2 quarters · filed 2019-02-26 | $3.80M derived: sum of 3 quarters · filed 2019-02-26 | $4.60M 10-K · filed 2019-02-26 | $4.65M 10-K · filed 2017-02-28 | |||
| 2016-09-30 | $3.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $3.60M derived: sum of 2 quarters · filed 2017-11-03 | $4.40M 10-Q · filed 2017-11-03 | $4.44M 10-Q · filed 2016-11-04 | $4.61M derived: sum of 4 quarters · filed 2018-02-22 | |||
| 2016-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $1.00M 10-Q · filed 2017-08-04 | $997.00K 10-Q · filed 2016-08-04 | $1.21M derived: sum of 3 quarters · filed 2018-02-22 | $1.68M derived: sum of 4 quarters · filed 2018-02-22 | |||
| 2016-03-31 | $800.00K 10-Q · filed 2017-05-09 | $777.00K 10-Q · filed 2016-04-29 | $1.01M derived: sum of 2 quarters · filed 2018-02-22 | $1.48M derived: sum of 3 quarters · filed 2018-02-22 | $2.44M derived: sum of 4 quarters · filed 2018-02-22 | |||
| 2015-12-31 | $214.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $678.00K derived: sum of 2 quarters · filed 2018-02-22 | $1.64M derived: sum of 3 quarters · filed 2018-02-22 | $8.60M 10-K · filed 2018-02-22 | $8.58M 10-K · filed 2016-02-29 | |||
| 2015-09-30 | $464.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $1.43M derived: sum of 2 quarters · filed 2015-11-06 | $8.39M 10-Q · filed 2015-11-06 | $14.91M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | $964.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $7.92M 10-Q · filed 2015-08-12 | $14.45M derived: sum of 3 quarters · filed 2017-02-28 | $16.71M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $6.96M 10-Q · filed 2015-04-30 | $13.48M derived: sum of 2 quarters · filed 2017-02-28 | $15.74M derived: sum of 3 quarters · filed 2017-02-28 | $19.68M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $6.52M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $8.79M derived: sum of 2 quarters · filed 2017-02-28 | $12.73M derived: sum of 3 quarters · filed 2017-02-28 | $20.40M 10-K · filed 2017-02-28 | $20.42M 10-K · filed 2015-02-26 | |||
| 2014-09-30 | $2.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $6.20M derived: sum of 2 quarters · filed 2014-11-05 | $13.88M 10-Q · filed 2014-11-05 | $20.75M derived: sum of 4 quarters · filed 2016-09-06 | ||||
| 2014-06-30 | $3.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $11.62M 10-Q · filed 2014-08-07 | $18.48M derived: sum of 3 quarters · filed 2016-09-06 | $22.85M derived: sum of 4 quarters · filed 2016-09-06 | ||||
| 2014-03-31 | $7.67M 10-Q · filed 2014-05-07 | $14.54M derived: sum of 2 quarters · filed 2016-09-06 | $18.91M derived: sum of 3 quarters · filed 2016-09-06 | $23.89M derived: sum of 4 quarters · filed 2016-09-06 | ||||
| 2013-12-31 | $6.87M derived: 8-K 12 month − 10-Q 9 month · filed 2016-09-06 | $11.23M derived: sum of 2 quarters · filed 2016-09-06 | $16.21M derived: sum of 3 quarters · filed 2016-09-06 | $17.80M 8-K · filed 2016-09-06 | $17.82M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $4.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $9.34M derived: sum of 2 quarters · filed 2013-11-07 | $10.93M 10-Q · filed 2013-11-07 | $13.66M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-06-30 | $4.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $6.57M 10-Q · filed 2013-08-08 | $9.30M derived: sum of 3 quarters · filed 2015-02-26 | $11.81M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2013-03-31 | $1.59M 10-Q · filed 2013-05-08 | $4.32M derived: sum of 2 quarters · filed 2015-02-26 | $6.83M derived: sum of 3 quarters · filed 2015-02-26 | $8.94M derived: sum of 4 quarters · filed 2015-02-26 | ||||
| 2012-12-31 | $2.73M derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-02-26 | $5.24M derived: sum of 2 quarters · filed 2015-02-26 | $7.36M derived: sum of 3 quarters · filed 2015-02-26 | $9.00M 10-K · filed 2015-02-26 | $9.02M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $2.51M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2013-02-28 | $4.62M derived: sum of 2 quarters · filed 2013-02-28 | $6.27M 10-Q/A · filed 2013-02-28 | |||||
| 2012-06-30 | $2.11M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2013-02-28 | $3.76M 10-Q/A · filed 2013-02-28 | ||||||
| 2012-03-31 | $1.65M 10-Q/A · filed 2013-02-28 | |||||||
| 2011-12-31 | $8.80M 10-K · filed 2014-02-28 | $8.76M 10-K · filed 2012-02-28 | ||||||
| 2010-12-31 | $3.80M 10-K/A · filed 2013-02-28 | |||||||
| 2009-12-31 | $1.10M 10-K/A · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |